Not a good buy right now for an impatient investor: the primary trend is still bearish (SMA_200 > SMA_20 > SMA_5) and the near-term pattern stats skew negative (-8.24% next week, -2.56% next month).
A short-term oversold bounce is possible (RSI_6 ~14), but without Intellectia entry signals and with heavy downside momentum recently (-7.65% regular session), odds favor chop/continuation lower rather than a clean reversal.
Volatility: IV_30d 272.65 vs historical vol 91.01; IV percentile 96.33 / IV rank 92.35 = extremely elevated (options pricing in large moves / stress).
Activity: Today’s volume 54 is far below the 5D/10D avg volumes (~2221/1908), so today’s put-skew may be noisy; however, today vs 30D avg volume shows 11.87, indicating a spike versus its own recent baseline.
OI scale: Call OI 321,156 vs Put OI 32,336 (skewed to calls), but that does not prevent the stock from falling if calls are part of covered strategies or stale positioning.
Technical Summary
Sell
9
Buy
5
Positive Catalysts
Technical mean-reversion setup: RSI_6 in extreme oversold territory increases the chance of a short, sharp bounce.
Support proximity: Price ~3.48 is not far above S2 3.295, where dip-buying attempts often appear.
No negative news flow in the last week (no fresh headline catalyst accelerating the selloff).
Neutral/Negative Catalysts
suggests rallies can be sold until trend breaks.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 4,110,169 (flat YoY at 0.00%), indicating no growth.
Profitability: Net income -216,742,056 (still a very large loss; YoY change looks distorted but the absolute level is deeply negative).
Gross margin: reported as 100 (flat YoY), which is unusual relative to the large net loss and suggests the snapshot may reflect accounting/classification effects; regardless, bottom-line performance is materially negative.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating changes or price target updates were provided, so the recent Street trend cannot be verified from this dataset.
Wall Street-style pros (inferred): oversold technicals could spark a bounce; call-heavy open interest suggests some participants are positioned for upside.
Wall Street-style cons (inferred): persistent downtrend, extremely high IV (risk), and very weak/negative earnings profile with flat revenue—hard to justify immediate buying without a catalyst.
Wall Street analysts forecast ETHZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ETHZ is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast ETHZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ETHZ is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
